$144.01
-10.00-6.49%
Last update: Nov 5, 11:24 AM
Belite Bio Inc
BLTENASDAQ
The average analyst price target for Belite Bio is $197.22, 36.9% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $80 to $303. The latest change came on Sep 9, 2026, when Mizuho raised its price target on Belite Bio from $220 to $234 and kept an Outperform rating.
Price Target Range — 13 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
